Peterson Katharine
SEC insider (Form 3/4/5 filer). CIK 0002022214. Chief Accounting Officer at Acrivon Therapeutics, Inc. (ACRV). 11 reported Form 4/5 transactions since Sep 2024; latest on Aug 18, 2026. Located in WATERTOWN, MA.
Companies Peterson Katharine has filed insider reports for
- Acrivon Therapeutics, Inc. (ACRV): Officer, Chief Accounting Officer
Peterson Katharine
CIK: 0002022214
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Acrivon Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Aug 18, 2026ACRV
Acrivon Therapeutics, Inc.
SaleDirect101 shares at avg. $2.01$203.01 - May 18, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirect14.2K shares- - May 14, 2026ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect99 shares at avg. $1.92$190.08 - Mar 1, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
31.9K shares- - Feb 14, 2026ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect116 shares at avg. $1.63$189.08 - Nov 14, 2025ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect99 shares at avg. $2.24$221.76 - Aug 14, 2025ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect99 shares at avg. $1.39$137.61 - May 14, 2025ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect99 shares at avg. $1.14$112.86 - Mar 1, 2025ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
31.9K shares- - Feb 14, 2025ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect116 shares at avg. $5.42$628.72
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 18, 2026 | ACRV Acrivon Therapeutics, Inc. | Sale | 101 | $2.01 | $203 | Direct |
| May 18, 2026 | ACRV Acrivon Therapeutics, Inc. | Award | 14,227 | - | $0 | Direct |
| May 14, 2026 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 99 | $1.92 | $190 | Direct |
| Mar 1, 2026 | ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 31,900 | - | - | Direct |
| Feb 14, 2026 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 116 | $1.63 | $189 | Direct |
| Nov 14, 2025 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 99 | $2.24 | $222 | Direct |
| Aug 14, 2025 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 99 | $1.39 | $138 | Direct |
| May 14, 2025 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 99 | $1.14 | $113 | Direct |
| Mar 1, 2025 | ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 31,900 | - | - | Direct |
| Feb 14, 2025 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 116 | $5.42 | $629 | Direct |
1-10 of 11 transactions